MIREYA MARTINEZ: Open Payments
NPI 1982283321 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,140 in 95 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $1,262 · 2025 $2,140
Food & beverage: $1,888Education: $252
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $414 |
| ABBVIE INC. | 21 | $306 |
| Astellas Pharma US Inc | 6 | $270 |
| Otsuka America Pharmaceutical, Inc. | 8 | $168 |
| Lilly USA, LLC | 12 | $159 |
| Novo Nordisk Inc | 8 | $146 |
| Antares Pharma, Inc. | 1 | $121 |
| ConvaTec Inc. | 2 | $109 |
| Axsome Therapeutics, Inc. | 3 | $87 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $68 |
Products named: FARXIGA, VRAYLAR, REXULTI, MOUNJARO, BOTOX, XYOSTED, INNOVAMATRIX AC, JARDIANCE.
Industry payments across TX — which companies pay providers there.
